For citations:
Nikitin A.E., Averin E.E., Rozhkov D.E., Sozykin A.V., Procenko G.A. Alirocumab Administration Experience to Achieve Low Density Lipoprotein Cholesterol Target Levels in Secondary Prevention of Cardiovascular Disease. Rational Pharmacotherapy in Cardiology. 2020;16(1):33-39. (In Russ.) https://doi.org/10.20996/1819-6446-2020-02-06